Table 1.
Metabolite | Blood pressure change | Mechanisms | |
---|---|---|---|
Short chain fatty acids | Acetate | Lower | 1. Activate Treg cells, enhance mRNA levels of Tjp1.24 2. Reduced expression of IL17a and IL6.24 |
Propionate | Increase or Lower | 1. Activate Olfr78 to raise blood pressure,30 while activate Gpr41 to lower blood pressure.28 2. Attenuate T cells responses to Ang II, and reduce Th17 and memory T cells, leading to a decrease in blood pressure.26 |
|
Butyrate | Lower | 1. Enhance β-oxidation of the intestinal mucosa.32 2. Alleviate immune inflammatory reactions.32 |
|
Trimethylamine-N-oxide | Increase | 1. Enhance the pro-hypertensive effect of Ang II.36 2. Decrease vascular compliance, induce endothelial dysfunction, and atherosclerosis.38 |
|
Bile acid | Lower | 1. Lower succinate, a pro-hypertensive metabolite.40 2. Activate multiple receptors, including FXR, PXR, VDR, and TGR5.42,43 |
|
H2S | Lower | 1. Dilate peripheral vessel through K-ATP channels.58 2. Attenuate Ang II-dependent autonomic dysfunction.59 3. Improve endothelial by activating the PPARδ/eNOS pathway.60 4. Inhibit renin synthesis and release.61 |
|
Serotonin | Increase or Lower | 1.Activate vagal nerve and strong vasoconstriction.62,63 2.Collaborate with enteric nervous system and the autonomic nervous system.64 |